SYNLAB International GmbH has acquired Yhtyneet Medix Laboratoriot Oy
|Yhtyneet Medix Laboratoriot Oy|
SYNLAB acquires 100 % of the shares in Yhtyneet Medix Laboratoriot Oy. Aventum acted as advisor to Aho Group and Minerva Foundation and other selling shareholders of YML.
|Global M&A Offices||
Aventum Partners (Global M&A Finland)
|Global M&A Advisory||Advisor to the seller|
Aventum Partners acted as an adviser to Aho Group and Minerva Foundation and other selling shareholders on the sale of Yhtyneet Medix Laboratoriot (YML).
YML is the leading privately held clinical laboratory company in Finland offering comprehensive central laboratory services in the fields of clinical chemistry, clinical microbiology, pathology and genetics as well as in therapeutic drug testing, drugs of abuse testing and doping control in sports. In addition to 3 million laboratory tests carried out annually in its central laboratory, YML also covers web-based infectious disease home testing services, point-of-care testing in local laboratories and specimen collection services at customer locations. With approximately 150 employees, YML generated revenues exceeding EUR 15 million in 2017.